GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amryt Pharma PLC (NAS:AMYT) » Definitions » Shiller PE Ratio

Amryt Pharma (Amryt Pharma) Shiller PE Ratio : (As of Jun. 06, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Amryt Pharma Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Amryt Pharma Shiller PE Ratio Historical Data

The historical data trend for Amryt Pharma's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amryt Pharma Shiller PE Ratio Chart

Amryt Pharma Annual Data
Trend Mar12 Mar13 Mar14 Mar15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Amryt Pharma Quarterly Data
Dec16 Jun17 Dec17 Jun18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Amryt Pharma's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Amryt Pharma's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amryt Pharma's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Amryt Pharma's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Amryt Pharma's Shiller PE Ratio falls into.



Amryt Pharma Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Amryt Pharma's E10 for the fiscal year that ended in Dec21 is calculated as:

For example, Amryt Pharma's adjusted earnings per share data for the fiscal year that ended in Dec21 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec21 (Change)*Current CPI (Dec21)
=0.02/114.7000*114.7000
=0.020

Current CPI (Dec21) = 114.7000.

Amryt Pharma Annual Data

Earnings per Share (Diluted) CPI Adj_EPS
201203 -0.012 95.400 -0.014
201303 -0.327 97.800 -0.384
201403 -0.261 99.300 -0.301
201503 -3.383 99.600 -3.896
201612 -1.508 102.200 -1.692
201712 -4.218 105.000 -4.608
201812 -3.328 107.100 -3.564
201912 -4.150 108.500 -4.387
202012 -3.300 109.400 -3.460
202112 0.020 114.700 0.020

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Amryt Pharma  (NAS:AMYT) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Amryt Pharma Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Amryt Pharma's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Amryt Pharma (Amryt Pharma) Business Description

Traded in Other Exchanges
N/A
Address
196 High Road, Dept 920A, Wood Green, London, GBR, N22 8HH
Amryt Pharma PLC is a specialty pharmaceutical company. It is focused on developing and delivering new treatments to help improve the lives of patients with rare or orphan diseases. It holds an exclusive license to sell Lojuxta (lomitapide) for adults, across the European Union and other territories including the Middle East, North Africa, Turkey and Israel. Lojuxta is used to treat a rare life-threatening disease called Homozygous Familial Hypercholesterolemia. Myalept (metreleptin) is an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients. It derives most of the revenue from the European Economic Area (EEA).

Amryt Pharma (Amryt Pharma) Headlines